IGB strives to transfer the technology developed in its laboratories into commercial applications and operates as an incubator. IGB fostered the faculty founding of several startup companies. The success rate of these startup companies is well above the national average. These include:
- Antigen Discovery Inc. (Irvine, CA) [faculty founder: P. Felgner]. Antigen discovery is a
proteome-on-a chip company for antigen discovery and other immunological applications. IGB
faculty were instrumental in helping the company develop its protein chip technology as well as
the computational technologies required for analyzing the complex signals produced by these
- Verdezyne, Inc. (Carslbad, CA) [faculty founders: G.W. Hatfield, R Lathrop]. Verdezyne is an
industrial biotechnology company that is leveraging technologies developed at UCI to produce
industrial chemicals from renewable non-food sources. They have developed technologies and are
commercializing processes that create a positive impact on the environment by replacing
important petrochemicals with chemicals produced by microorganisms from sustainable
feedstocks, at a lower cost. Verdezyne currently employs more than 100 employees including
several UCI graduates.
- Reaction Explorer, LLC (Irvine, CA) [faculty founders: P. Baldi and former MD/PhD Student J
Chen]. Reaction Explorer has developed an expert system for organic reactions in chemistry
which is used to power an interactive education system for college-level organic chemistry. Wiley
has acquired an exclusive license to the system and is distributing it worldwide.
- Actavalon Inc. (Corona del Mar, CA) [faculty founders: R Amaro, G. W. Hatfield, P Kaiser, R.
Lathrop, S. Rychnovsky]. Actavalon is a pharmaceutical company employing proprietary
computational, biological, and chemical methods to develop small molecule drugs for treatment
of a broad spectrum of human cancers.
- 4Design Biosciences LLC (Corona del Mar) [faculty founders: S George, G.W. Hatfield, C.C.
Hughes, A. Lee]. 4D scientists have pioneered the development of high-throughput microfluidic
devices for multiple physiologically-relevant 3D human micro-organ systems that receive their
oxygen, nutrients, and drugs through living blood vessels, just as tissues do in the body.